On-site toxicologic pathology and related investigative research services
Award Notice Posted
- Solicitation number
- 09-222-SOL-00029
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Awarded
- to Toxicologic Pathology Associates Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSF223201000001C Federal contract award
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
The National Center for Toxicological Research has a requirement for on-site toxicologic pathology and related investigative research services. Qualified professional, technical and administrative staff will be required to perform tasks in the following 14 major services and functional support areas: 1) Toxicologic Pathology; 2) Immunopathology; 3) Molecular Pathology Techniques; 4) Biomarker relevant specialty techniques; 5) Digital Pathology/Image Analysis; 6) Clinical Pathology; 7) Teratology/Fertility/Reproductive System; 8) Digital Imagery; 9) Translational Toxicology, Critical Path Investigative Research Support and Pathology-related Collaboration; 10) Research and Publication, and Professional Services; 11) Administrative Services and Management; 12) Health and Safety of Contract Employees and Laboratory Environment Protection; 13) Repository Services; and 14) Quality Control of Pathology Activities, Data and Case Accountability. The 14 functional areas are broken into the following 9 tasks, which includes sub-tasks: 1. Necropsy and Gross Pathology, 2. Clinical Pathology, 3. Histotechniques (Routine and Specialized), 4. Reporting, 5. Research, Publication, Professional Services, 6. Administrative Services, 7. Environment, Safety, and Health, 8. Quality Control, and 9. Quality Assurance Unit (In support of research protocols required for GLP designated studies only).
Laboratory and office space, laboratory equipment and supplies will be government furnished as specified in the solicitation. A Fixed Price Type Contract with reimbursable components will result from this solicitation. We anticipate award of a base period of one year and four one-year option periods. The proposed acquisition is a 100 % small business set-aside. The approximate release date for the solicitation will be on about July 31, 2009. Interested parties may access and download the solicitation through the Federal Business Opportunity website at http://www.fbo.gov. A pre-proposal conference and site visit is planned to be held at NCTR on or about August 7, 2009. The solicitation will specify the exact date and time for the pre-proposal conference as well as the planned agenda. The applicable North American Industry Classification System (NAICS) code is 541711-Research and Development in Biotechnology. The small business size standard is 500 employees. Questions regarding this procurement may be directed to Regina Williams at (870) 543-7012 ph, via fax at (870) 543-7990, or email regina.williams@fda.hhs.gov.
Update #1 ·
The National Center for Toxicological Research has a requirement for on-site toxicologic pathology and related investigative research services. Qualified professional, technical and administrative staff will be required to perform tasks in the following 14 major services and functional support areas: 1) Toxicologic Pathology; 2) Immunopathology; 3) Molecular Pathology Techniques; 4) Biomarker relevant specialty techniques; 5) Digital Pathology/Image Analysis; 6) Clinical Pathology; 7) Teratology/Fertility/Reproductive System; 8) Digital Imagery; 9) Translational Toxicology, Critical Path Investigative Research Support and Pathology-related Collaboration; 10) Research and Publication, and Professional Services; 11) Administrative Services and Management; 12) Health and Safety of Contract Employees and Laboratory Environment Protection; 13) Repository Services; and 14) Quality Control of Pathology Activities, Data and Case Accountability. The 14 functional areas are broken into the following 9 tasks, which includes sub-tasks: 1. Necropsy and Gross Pathology, 2. Clinical Pathology, 3. Histotechniques (Routine and Specialized), 4. Reporting, 5. Research, Publication, Professional Services, 6. Administrative Services, 7. Environment, Safety, and Health, 8. Quality Control, and 9. Quality Assurance Unit (In support of research protocols required for GLP designated studies only).
Laboratory and office space, laboratory equipment and supplies will be government furnished as specified in the solicitation. A Fixed Price Type Contract with reimbursable components will result from this solicitation. We anticipate award of a base period of one year and four one-year option periods. The proposed acquisition is a 100 % small business set-aside. The approximate release date for the solicitation will be on about June 29, 2009. Interested parties may access and download the solicitation through the Federal Business Opportunity website at http://www.fbo.gov. A pre-proposal conference and site visit is planned to be held at NCTR on or about July 8, 2009. The solicitation will specify the exact date and time for the pre-proposal conference as well as the planned agenda. The applicable North American Industry Classification System (NAICS) code is 541711-Research and Development in Biotechnology. The small business size standard is 500 employees. Questions regarding this procurement may be directed to Regina Williams at (870) 543-7012 ph, via fax at (870) 543-7990, or email regina.williams@fda.hhs.gov.
Files
| File | Type | Posted |
|---|---|---|
| Amendment 02.pdf | ||
| Amendment 01.pdf | ||
| Sol pkg 1 of 3.pdf | ||
| Sol pkg 3 of 3.pdf | ||
| Sol pkg 2 of 3.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity